EAGAN, Minn., Sept. 15, 2021 /PRNewswire/ — Makana Therapeutics today received a $650,000 KidneyX Artificial Kidney Prize for their work to increase the supply of kidney donor organs through pig-to-human xenotransplants. Xenotransplantation is the process of transplanting organs or tissues between members of different species into humans, thus addressing the
The FDA greenlights α-Gal allergy-safe meat, but its makers have organs for transplants in their sights. The first genetically engineered pig products could soon be coming to a dinner plate—or pharmacy—near you. Late last year, the US Food and Drug Administration (FDA) authorizeda facility in northern Iowa to raise hogs
Surrogen’s Vice President of Research & Development, Dr. Adrienne Watson, PhD, is featured in GeneWorx Capital Webinar discussing the “Power of the Pig” in finding the next generation of Cancer Therapies.
EAGAN, Minn., Oct. 14, 2020 /PRNewswire/ — Acceligen, the leading Precision Breeding company for food animals, today announced that they are opening a new office in Aracatuba, Sao Paolo State to better meet the needs for commercialization of their traits to improve cattle, swine, and fish in Brazil.
EAGAN, Minn., Sept. 24, 2020 /PRNewswire/ — Acceligen, a Recombinetics Inc. company, today announced that it received a grant from the Bill & Melinda Gates Foundation to develop bovine genetics optimized with traits desirable to smallholder dairy farmers. The breeding program will contribute to more sustainable production by using traits
A grant made possible by the Bill and Melinda Gates Foundation is meant to develop bovine genetics optimized with traits desirable to smallholder dairy farmers. Acceligen, a recognized global leader in the development, deployment, and commercialization of precision animal breeding technologies. They are launching a program for precision crossbreeding of